Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Radiation Injuries 4Medulloblastoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Pinealoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Gliosarcoma 2Glioma, Subependymal 2Glioma 2Glioblastoma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Cognitive Dysfunction 2Breast Neoplasms 2Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Pain 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1Memory Disorders 1Lung Neoplasms 1

Interventions

Exercise 4Walking 2Memantine 2Donepezil 2beta Carotene 1Vitamin E 1Ultraviolet Therapy 1Time 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Riluzole 1Rehabilitation, Vocational 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Quality of Life 1Population Groups 1Pioglitazone 1Palliative Care 1Neuropsychological Tests 1Mindfulness-Based Stress Reduction 1Methods 1Interviews as Topic 1Ibuprofen 1Hormones 1Hematologic Tests 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Cognitive Dysfunction × Donepezil × Clear all
NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed
276 enrolled 33 charts
Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

NCT00594633 2016-01-14

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
25 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡